2m 2m 2m 2m 2m 2m 2m
Harrow (HROW)
NASDAQ
$33.23+$0.37 (+1.11%)
Price as of Jun 03, 2026 6:09 PM EDT- $1.3BMarket Cap
- 12.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Harrow (HROW)
$33.23+$0.37 (+1.11%)
Earnings Score
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | 0 | ||
Low Earnings Volatility | 6 |
Momentum Score
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -24.51% | ||
12-Month Momentum | 36.42% | ||
3-Month Risk Adjusted Momentum | -72.17% | ||
12-Month Risk Adjusted Momentum | 61.58% |
True Yield
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -3.53% |
Financial Health Score
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |